Autek China Inc
SZSE:300595

Watchlist Manager
Autek China Inc Logo
Autek China Inc
SZSE:300595
Watchlist
Price: 16.88 CNY -1.4%
Market Cap: 15.1B CNY
Have any thoughts about
Autek China Inc?
Write Note

Gross Margin
Autek China Inc

72.7%
Current
75%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.7%
=
Gross Profit
1.3B
/
Revenue
1.8B

Gross Margin Across Competitors

Country CN
Market Cap 15.4B CNY
Gross Margin
73%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 38.2B CHF
Gross Margin
55%
Country DK
Market Cap 177.1B DKK
Gross Margin
68%
Country US
Market Cap 16.3B USD
Gross Margin
70%
Country KR
Market Cap 10.3T KRW
Gross Margin
15%
Country CN
Market Cap 51B CNY
Gross Margin
72%
Country US
Market Cap 6.7B USD
Gross Margin
65%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country UK
Market Cap 4.6B GBP
Gross Margin
56%
Country US
Market Cap 5.6B USD
Gross Margin
47%
No Stocks Found

Autek China Inc
Glance View

Market Cap
15.1B CNY
Industry
Health Care

Autek China Inc. stands as an emblematic figure in the dynamic landscape of medical devices and biotechnology in China. Rooted in its mission to innovate within the realms of diagnostic imaging and therapeutic ultrasound equipment, the company has maneuvered through this niche market by leveraging both cutting-edge technology and strategic partnerships. Autek's portfolio includes a range of high-quality ultrasound machines and imaging solutions that cater to the rapidly evolving needs of hospitals and clinics. By capitalizing on the growing demand for advanced healthcare services in China, Autek has tailored its product offerings to resonate with local market needs while maintaining competitive pricing strategies. This keen understanding of market dynamics allows Autek to maintain a robust sales pipeline and forge sturdy relationships within the medical community, driving its revenue growth engine. The company's operational blueprint hinges on an impressive blend of research-driven innovation and effective distribution networks. Autek continually invests in research and development, aspiring to push technological boundaries and uphold its reputation as a pioneer in the medical imaging sector. This investment lays the groundwork for creating state-of-the-art products that are not only technologically advanced but also user-friendly for medical professionals. Autek's adeptness at navigating regulatory landscapes ensures smooth market entry and expansion for its offerings. Furthermore, its strategic alliances with healthcare providers and government entities enhance its distribution network, ensuring that its products reach a wide spectrum of healthcare institutions across China. Autek makes its money by selling its technologically advanced and reliable devices, as well as providing ongoing support and maintenance services, forming the backbone of its revenue model and securing its position in the competitive arena.

Intrinsic Value
22.09 CNY
Undervaluation 24%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.7%
=
Gross Profit
1.3B
/
Revenue
1.8B
What is the Gross Margin of Autek China Inc?

Based on Autek China Inc's most recent financial statements, the company has Gross Margin of 72.7%.